Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-6-3
|
pubmed:abstractText |
Underpinned by increased confidence in cure of metastatic seminoma by chemotherapy during the past 12 years, three management strategies for Stage I seminoma have been evaluated by six collaborating centers within the Anglian Germ Cell Tumor Group. This paper evaluates the efficacy of surveillance, prophylactic radiotherapy and adjuvant chemotherapy, and discusses these differing management approaches.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
3-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8175442-Adult,
pubmed-meshheading:8175442-Carboplatin,
pubmed-meshheading:8175442-Combined Modality Therapy,
pubmed-meshheading:8175442-Humans,
pubmed-meshheading:8175442-Male,
pubmed-meshheading:8175442-Orchiectomy,
pubmed-meshheading:8175442-Pilot Projects,
pubmed-meshheading:8175442-Quality of Life,
pubmed-meshheading:8175442-Seminoma,
pubmed-meshheading:8175442-Testicular Neoplasms
|
pubmed:year |
1994
|
pubmed:articleTitle |
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?
|
pubmed:affiliation |
Dept. of Medical Oncology, Royal London Hospital, England.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|